Astrazeneca equity research - big pharma on the brink of future changes in oncology
The pharmaceutical industry is distinguished by a highly competitive market. Furthermore, various growth trends provide promising outlooks for the future development of the sector. Thus, competitors need to focus on measures such as strong R&D spending to be able to defend their positioning in t...
| Autor principal: | |
|---|---|
| Formato: | masterThesis |
| Idioma: | eng |
| Publicado em: |
2022
|
| Assuntos: | |
| Texto completo: | http://hdl.handle.net/10362/145367 |
| País: | Portugal |
| Oai: | oai:run.unl.pt:10362/145367 |
| Resumo: | The pharmaceutical industry is distinguished by a highly competitive market. Furthermore, various growth trends provide promising outlooks for the future development of the sector. Thus, competitors need to focus on measures such as strong R&D spending to be able to defend their positioning in the industry. These prospects compose the basis for further expansion while we assess two possible outcomes. |
|---|